What Are the Signs of Low GABA at Night?

Low functional GABA at night tends to present as a cluster: racing thoughts you cannot suppress, a wired-but-tired feeling where your body is exhausted but your brain will not shut off, waking between 2am and 4am with full alertness, nighttime anxiety that feels different from daytime worry, and difficulty returning to sleep once awake. Brain imaging research shows people with insomnia have approximately 30% lower GABA in the cortical regions that govern rumination suppression (Winkelman et al., 2008).

GABA (gamma-aminobutyric acid) is the brain’s primary inhibitory neurotransmitter — the calming neurotransmitter responsible for dampening arousal-promoting neural circuits during sleep. When GABAergic function is impaired, those arousal circuits stay active during hours when they should be suppressed.

This article covers what impaired GABAergic function feels like at night, what brain imaging has revealed, and how to distinguish GABA-related sleep disruption from other causes. For the mechanism in depth, see Can Low GABA Cause Waking Up at 3am?. Impaired GABA is one of several hormonal and neurochemical mechanisms that fragment sleep in men — the full overview is in Why Men’s Hormones Disrupt Sleep.


What Does Low GABA Feel Like at Night?

Low functional GABA at night feels like your brain cannot stop producing thoughts, even when your body is exhausted. The common experience is racing thoughts — not anxious content, but an inability to stop thinking. Your body may be physically fatigued while your mind runs. Once awake, returning to sleep can feel unachievable because arousal circuits that lack GABAergic restraint tend to self-perpetuate.

What Does Racing Thoughts From Low GABA Look Like?

Racing thoughts linked to impaired GABA are distinct from anxious rumination. The anterior cingulate cortex (ACC) — the brain region responsible for suppressing repetitive thought — shows reduced GABA in people with insomnia. Lower ACC GABA correlates with an inability to suppress mental activity, regardless of the emotional content of the thoughts (Plante et al., 2012).

Plante et al. (2012) measured GABA in 20 non-medicated adults with insomnia and 20 matched healthy controls. GABA was reduced in the ACC (p = 0.03) and the occipital cortex (p = 0.0005), but not in the thalamus — indicating the deficit is region-concentrated rather than brain-wide.

The racing thoughts are not a character problem or a stress management issue. They reflect insufficient inhibitory neurotransmission in the region of the brain that suppresses repetitive thinking.

Why Does the Wired-but-Tired Feeling Happen?

The wired-but-tired pattern — body exhausted, mind active — occurs because GABAergic impairment in sleep-regulatory circuits leaves arousal-promoting neurons insufficiently suppressed. Physical fatigue accumulates normally through adenosine buildup, but the neural “off” response that GABA provides is weakened, so the brain stays in a state of activation despite the body’s exhaustion.

GABA is what allows sleep-promoting regions (including the ventrolateral preoptic nucleus) to suppress the wakefulness-promoting circuits in the hypothalamus and brainstem. When GABAergic tone is insufficient, both states coexist: the body’s fatigue and the brain’s activation — that distinctly uncomfortable feeling of being wired rather than tired at the hour you need to be sleeping.

How Is Nighttime Anxiety From Low GABA Different From Daytime Anxiety?

Nighttime anxiety linked to impaired GABA tends to be diffuse and content-free — a sense of unease or restlessness without an identifiable cause. Daytime anxiety is more often tied to identifiable stressors. The nighttime version reflects insufficient GABAergic inhibition of arousal circuits during a period when those circuits should be at their lowest activity.

If you wake at 2am or 3am and your mind is immediately sharp — fully alert, not drowsy — that pattern is more consistent with impaired GABAergic inhibition than with blood sugar fluctuation (which tends to produce grogginess) or nocturia (which produces a physical urge). Once the arousal circuit fires without sufficient GABAergic restraint, it tends to self-sustain — returning to sleep can take 45 minutes to two hours.


How Do You Know If Your GABA Is Low?

There is no standard test for brain GABA levels in routine practice. Brain imaging (magnetic resonance spectroscopy, or MRS) can measure cortical GABA but remains a research tool. Blood GABA levels do not reliably reflect brain GABA — a 2023 study found that people with insomnia can have normal serum GABA but downregulated GABA-A receptors. The practical approach is recognition through a nighttime pattern: racing thoughts, 2-4am waking with full alertness, nighttime anxiety without an identifiable cause, and difficulty returning to sleep (Xiang et al., 2023).

Why Don’t Blood Tests Detect Low GABA?

Serum GABA levels do not reliably reflect brain GABA function because the impairment in insomnia appears to occur at the receptor, not the neurotransmitter itself. Xiang et al. (2023) found no difference in circulating GABA between insomnia and control groups (p = 0.733), but GABA-A receptor alpha-1 subunit expression was reduced (p < 0.001).

Xiang et al. (2023) compared 30 adults with insomnia against 30 healthy controls, measuring both serum GABA and GABA-A receptor subunit mRNA from peripheral blood:

  • Serum GABA: No difference between groups (p = 0.733)
  • GABA-A receptor alpha-1 subunit mRNA: Reduced in insomnia (p < 0.001)
  • GABA-A receptor alpha-2 subunit mRNA: Reduced in insomnia (p = 0.001)

In healthy controls, serum GABA correlated positively with receptor expression — a relationship absent in the insomnia group. The problem may not be how much GABA is present, but whether the brain’s inhibitory receptors can respond to it.

Bar chart comparing serum GABA levels and GABA-A receptor alpha-1 and alpha-2 subunit mRNA expression between insomnia disorder and normal control groups
Serum GABA levels (left) showed no difference between insomnia and control groups, but GABA-A receptor alpha-1 and alpha-2 subunit mRNA (center, right) were reduced in insomnia. From Xiang et al., 2023, Frontiers in Psychiatry.

What Does Brain Imaging Show About GABA and Insomnia?

Magnetic resonance spectroscopy (MRS) studies consistently show lower cortical GABA in people with insomnia. Winkelman et al. (2008) found approximately 30% lower whole-brain GABA, and a 2020 study of 166 adults found that lower GABA in the anterior cingulate cortex tracked with shorter sleep duration (Park et al., 2020).

Winkelman et al. (2008): Sixteen unmedicated adults with insomnia had approximately 30% lower whole-brain GABA than 16 matched controls. Lower GABA correlated with more nighttime wakefulness (r = -0.71, p = 0.002).

Plante et al. (2012): GABA reductions were concentrated in the ACC (p = 0.03) and occipital cortex (p = 0.0005), but not the thalamus — region-concentrated, not brain-wide.

Park et al. (2020): In 166 adults, those sleeping fewer than 6 hours had lower ACC GABA than those sleeping 6 or more hours (p = 0.03). Glutamate and glutamine did not differ — the deficit was limited to the inhibitory neurotransmitter.

What Nighttime Pattern Identifies Low GABA?

The practical identifier is a cluster of co-occurring experiences: racing or repetitive thoughts at bedtime or upon waking, waking between 2am and 4am with full alertness (not grogginess), difficulty returning to sleep within 20-30 minutes, nighttime anxiety or restlessness without an identifiable cause, and physical exhaustion coexisting with mental activation.
  • Racing thoughts at sleep onset or upon waking — an inability to stop the stream of thought
  • Full alertness upon waking — the mind is sharp within seconds (contrast with the grogginess of blood sugar-related waking)
  • Difficulty returning to sleep — once awake, the return to sleep takes 30 minutes or longer
  • Nighttime anxiety without an identifiable trigger — diffuse unease rather than worry about something particular
  • Wired rather than tired — physical fatigue and mental activation coexisting

If this cluster is present in the absence of an obvious external cause (caffeine, alcohol, acute stress), impaired GABAergic function is a plausible contributor.


Does Low GABA Cause Anxiety at Night?

Yes — impaired GABAergic function is directly linked to nighttime anxiety. Research shows that anxiety and insomnia share a common GABAergic deficit, and the gut-brain axis may mediate both. A 2025 review found that disrupted gut microbiota can alter central GABA receptor expression, contributing to co-occurring anxiety and insomnia (Jiang et al., 2025). A 2026 randomized controlled trial showed a GABA-modulating probiotic reduced both insomnia severity and anxiety scores in 139 adults (Grant et al., 2026).

Why Do Anxiety and Insomnia Co-Occur So Often?

Anxiety and insomnia co-occur because they share an overlapping neurochemical deficit: reduced GABAergic inhibition. The anterior cingulate cortex — the same region with lower GABA in insomnia — also governs emotional regulation and rumination suppression. Impaired GABA in this region can produce both racing thoughts and anxiety as two presentations of the same underlying insufficiency (Plante et al., 2012; Jiang et al., 2025).

MRS studies confirm GABA deficits in both conditions, and the same receptor subtypes (GABA-A alpha-1 and alpha-2) are implicated in both (Jiang et al., 2025). The ACC governs both rumination suppression and emotional self-regulation — lower GABA in this region can produce both experiences from a single deficit.

What Weakens GABA Function Over Time?

Several factors can weaken GABAergic function: chronic stress downregulates GABA-A receptor subunits, aging reduces both GABA production and receptor density, chronic alcohol use enhances GABA activity initially but causes rebound receptor downregulation, disrupted gut microbiome composition reduces peripheral GABA production, and poor sleep itself further impairs GABA function — creating a self-reinforcing cycle.

Jiang et al. (2025) reviewed three pathways by which gut-derived GABA may influence the brain: direct absorption from the gastrointestinal tract into circulation, vagal afferent transmission from GABA-producing gut microbes to the brainstem, and microbiome-mediated modulation of central GABA receptor expression.

Diagram showing mechanisms by which gut-derived GABA affects the human body, including direct absorption, vagal nerve transmission, and microbiome-mediated modulation of central GABA receptor expression
Mechanisms of gut-derived GABA on the human body — including direct intestinal absorption, vagal afferent transmission, and microbiome-mediated modulation of central GABA receptors. From Jiang et al., 2025, Frontiers in Neuroscience.

Grant et al. (2026) tested this in a randomized, double-blind, placebo-controlled trial of 139 adults. After six weeks on a GABA-modulating probiotic (Lactiplantibacillus plantarum Lp815), 77.3% achieved a 4-point or greater insomnia improvement vs. 57.8% in placebo (p = 0.02). Anxiety scores were also reduced (p < 0.05), and urinary GABA rose within one week (p < 0.05) — inversely correlated with both insomnia severity (r = -0.30) and anxiety (r = -0.48) at week 2.


Does GABA Deficiency Affect Men Differently Than Women?

Emerging evidence suggests yes. Testosterone-derived neurosteroids act as positive modulators of GABA-A receptors — meaning men with declining testosterone may experience a compound loss of GABAergic tone that women do not. The Grant et al. (2026) probiotic trial showed sex-differentiated responses, with women showing an amplified anxiety reduction (p < 0.01). The intersection of testosterone decline and GABA receptor modulation is an active area of research.

Testosterone is metabolized into androstanediol, a positive allosteric modulator of GABA-A receptors — it enhances the receptor’s response to GABA (Reddy & Jian, 2010). As testosterone declines with age, this neurosteroid-mediated enhancement declines as well, compounding the age-related loss of GABA production and receptor density.

This may partly explain why sleep disruption in men during their 40s and 50s often presents with the wired-but-tired, racing-thought pattern characteristic of GABAergic impairment. The Grant et al. (2026) trial showed women had a stronger anxiety reduction (p < 0.01 for women vs. p < 0.05 overall), suggesting sex-differentiated GABAergic responses not yet fully understood. A fuller discussion is in Does GABA Affect Testosterone and Sleep in Men?.


The racing thoughts, wired-but-tired pattern, and 3am waking associated with impaired GABA overlap with other sleep disruption mechanisms. Cortisol rhythm changes, testosterone decline, metabolic instability, and inflammatory processes might all be contributing alongside weakened GABAergic function. In many people, more than one of these is involved — and addressing only one while the others persist can leave the sleep disruption partially unresolved.

Find out which causes might be driving your 3am wakeups →


Frequently Asked Questions

What Causes GABA Deficiency?

GABAergic function can weaken through several pathways: chronic stress downregulates GABA-A receptor subunits (Xiang et al., 2023), aging reduces both GABA production and receptor density, disrupted gut microbiome composition decreases peripheral GABA production (Jiang et al., 2025), chronic alcohol use enhances GABA activity initially but causes rebound receptor downregulation, and poor sleep itself further impairs GABA function — creating a cycle where low GABA causes poor sleep, which further reduces GABAergic function.

Is GABA Deficiency the Cause of Primary Insomnia?

GABAergic impairment is one of the well-supported neurochemical mechanisms in primary insomnia. Brain imaging studies consistently show lower cortical GABA (Winkelman et al., 2008; Plante et al., 2012; Park et al., 2020), and receptor subunit downregulation has been confirmed in blood biomarker studies (Xiang et al., 2023). However, insomnia is multifactorial — GABAergic impairment is a primary driver, but not the only one. For a deeper look at how GABA deficit leads to 3am waking, see *Can Low GABA Cause Waking Up at 3am?*.

How Do You Test for GABA Deficiency?

There is no standard test available in routine practice. Magnetic resonance spectroscopy can measure cortical GABA but is a research tool. Serum GABA levels do not reliably reflect brain GABA function — Xiang et al. (2023) showed normal serum GABA alongside downregulated receptors in insomnia. Recognition through the nighttime cluster — racing thoughts, 2-4am waking with full alertness, nighttime anxiety without an identifiable trigger, difficulty returning to sleep — is currently the practical approach.

Related Reading


References

1. Winkelman JW, Buxton OM, Jensen JE, et al. Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep. 2008;31(11):1499-1506. PubMed

2. Plante DT, Jensen JE, Schoerning L, Winkelman JW. Reduced gamma-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder? Neuropsychopharmacology. 2012;37(6):1548-1557. PubMed

3. Park S, Kang I, Edden RAE, et al. Shorter sleep duration is associated with lower GABA levels in the anterior cingulate cortex. Sleep Medicine. 2020;71:1-7. PubMed

4. Xiang T, Liao J, Cai Y, et al. Impairment of GABA inhibition in insomnia disorders: evidence from the peripheral blood. Frontiers in Psychiatry. 2023;14:1134434. PubMed

5. Zhu W, Yuan H, Bhatt S, et al. GABA and its receptors in insomnia. Heliyon. 2024;10(24):e40665. PubMed

6. Jiang C, Chen Y, Sun T. From the gut to the brain: mechanisms and applications of gamma-aminobutyric acid (GABA) for anxiety and insomnia. Frontiers in Neuroscience. 2025;19:1570173. PubMed

7. Grant AD, et al. Lactiplantibacillus plantarum Lp815 improves sleep and increases urinary GABA in a randomized, double-blind, placebo-controlled study of sleep disturbance. Scientific Reports. 2026. PubMed

8. Reddy DS, Jian K. The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors. Journal of Pharmacology and Experimental Therapeutics. 2010;334(3):1031-1041. PubMed


Written by Kat Fu, M.S., M.S. · Last reviewed: April 2026 · 8 references cited

Scroll to Top